维普中文期刊产品整合服务
23篇 您的检索式:作者名="Colevas AD"
    题名 作者 年代 出处 被引量
1Chemotherapy options for patients with metastaticor recurrenl: squamous cell carcinoma of the head and neck显示文摘Colevas AD 2006J ClinOncol2006,24,17:1
2Chemotherapy options for patients with metastatic or recurrent squamous cell carcinoma of the head and neck显示文摘Colevas AD 2006J Clin Onco12006,24,17:1
3Docetaxel, cisplatin, and 5 - fluorouracil - based induction chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck: the Dana Farber Cancer Institute experience显示文摘Haddad R Colevas AD Tishler R 2003Cancer2003,97,2:1
4Induction chemotherapy with docetaxel,cisplatin,fluorouracil,and leucovorin for squamous cell carcinoma of the head and neck:a phase Ⅰ /Ⅱ trial显示文摘 Busse PM Norris CM 1998J Clin Oncol1998,16,:1
5Phase Ⅱ trial of docetaxel,cisplatin,fluorouracil,and leucovorin as induction for squamous cell carcinoma of the head and neck显示文摘 Norris CM Tishler RB 1999J Clin Oncol1999,17,:1
6Phase Ⅰ /Ⅱ trial of outpatient docetaxel,cisplatin,5-fluorouracil,leucovorin (opTPFL) as induction for squamous cell carcinoma of the head and neck (SCCHN)显示文摘 Norris CM Tishler RB 2002Am J Clin Oncol2002,25,:1
7Chemotherapy options for patients with metastatic or recurrent squmous cell carcinoma of the head and neck 显示文摘Colevas AD 2006J Clin Oncol2006,24,17:1
8Induction chemotherapy with docetaxel, cisplatin, fluorouracil, and leucovorin for squamous cell carcinoma of the head and neck: a phase I/II trial显示文摘Colevas AD Busse PM Norris CM 1998J Clin Oncol1998,16,4:1
9Docetaxel,cisplatin and 5-fluorouracil based induction chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck:The Dana Farber Cancer Institute experience显示文摘 Colevas AD Tishler R 2002Cancer2002,97,:1
10Chemotherapy options for patients with meta- static or recurrent squamous eell carcinoma of the head and neck 显示文摘Colevas AD 2006J Clin Oncol2006,24,17:1
11Differentiated thyroid cancer: focus on emerging treatments for radioactive iodine-refractory patients 显示文摘Gruber JJ Colevas AD 2015Oncologist2015,20,2:1
12The NCI common Terminology Criteria forAdverse Events (CTCAE) v310 is the new standard for oncology clinical trials显示文摘Colevas AD Setser A CTEP/NCI 2007Clin Oncol2007,22,14:1
13Development of a comprehensive grading system for the adverse effects of cancer treatment显示文摘Trotti A Colevas AD Setser A 2003Semin Radiat Oncol2003,13,3:1
14Development of a com- prehensive grading system for the adverse effects of cancer treatment显示文摘Tortti A Colevas AD Setser A 2003Semin Radiat Oncol2003,13,3:1
15A Phase Ⅰ/Ⅱ trial of concurrent docetaxel and radiation after induction chemotherapy in patients with poor prognosis squamous cell carcinoma of the head and neck显示文摘Tishler RB Jr Norris CM Colevas AD 2002Cancer2002,95,7:1
16Patient-reported outcomes and the evolution of adverse event reporting in oncology 显示文摘Trotti A Colevas AD Setser A 2007J Clin Oncol2007,25,32:1
17Phase Ⅱ trial of doeetaxel, cisplatin, fluorouracil and leucovorin as induction for squamous cell carcinoma of the head and neck显示文摘Colevas AD Norris CM Tishler RB 1999J Clin Oncol1999,17,:1
18Docetaxel, cisplatin, and 5-fluorouracil-based induction chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck: the Dana Farber Cancer Institute experience显示文摘Haddad R Colevas AD Tishler R 2003Cancer2003,97,2:1
19Induction chemotherapy with docetaxel, cisplatin, 5-fluorouracil, and leucovorin for squamous cell carcinoma of the head and neck: a phase Ⅰ/Ⅱ trial 显示文摘Colevas AD Busse PM Norris CM 1998J Clin Oncol1998,16,4:1
20A phase Ⅱ trial of docetaxel, cisplatin, fluorouracil, and leucovorin as induction for squamous cell carcinoma of the head and neck 显示文摘Colevas AD Norris CM Tishler RB 1999J Clin Oncol1999,17,11:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费